LU87009A1 - Compositions pharmaceutiques a liberation prolongee - Google Patents
Compositions pharmaceutiques a liberation prolongee Download PDFInfo
- Publication number
- LU87009A1 LU87009A1 LU87009A LU87009A LU87009A1 LU 87009 A1 LU87009 A1 LU 87009A1 LU 87009 A LU87009 A LU 87009A LU 87009 A LU87009 A LU 87009A LU 87009 A1 LU87009 A1 LU 87009A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- pharmaceutical composition
- composition according
- acetylsalicylic acid
- hydroxypropyl
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868624213A GB8624213D0 (en) | 1986-10-09 | 1986-10-09 | Sustained release pharmaceutical compositions |
| GB8624213 | 1986-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU87009A1 true LU87009A1 (fr) | 1988-05-03 |
Family
ID=10605478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU87009A LU87009A1 (fr) | 1986-10-09 | 1987-10-06 | Compositions pharmaceutiques a liberation prolongee |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JPS63101334A (da) |
| KR (1) | KR880004801A (da) |
| AU (1) | AU7942087A (da) |
| BE (1) | BE1000732A5 (da) |
| CA (1) | CA1332809C (da) |
| CH (1) | CH675831A5 (da) |
| DE (1) | DE3733540A1 (da) |
| DK (1) | DK527487A (da) |
| ES (1) | ES2014518A6 (da) |
| FI (1) | FI874414A (da) |
| FR (1) | FR2604902B1 (da) |
| GB (2) | GB8624213D0 (da) |
| GR (1) | GR871550B (da) |
| HU (1) | HU201875B (da) |
| IL (1) | IL84104A0 (da) |
| IT (1) | IT1221493B (da) |
| LU (1) | LU87009A1 (da) |
| NL (1) | NL8702294A (da) |
| NO (1) | NO874200L (da) |
| NZ (1) | NZ222083A (da) |
| PH (1) | PH24227A (da) |
| PT (1) | PT85880B (da) |
| SE (1) | SE8703889L (da) |
| ZA (1) | ZA877617B (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5948437A (en) * | 1996-05-23 | 1999-09-07 | Zeneca Limited | Pharmaceutical compositions using thiazepine |
| US5895663A (en) * | 1997-07-31 | 1999-04-20 | L. Perrigo Company | Pseudoephedrine hydrochloride extended-release tablets |
| KR100660594B1 (ko) * | 1999-03-31 | 2006-12-22 | 얀센 파마슈티카 엔.브이. | 방출 조절형 제제중의 프리젤라틴화 전분 |
| US6242003B1 (en) | 2000-04-13 | 2001-06-05 | Novartis Ag | Organic compounds |
| US20060127474A1 (en) | 2001-04-11 | 2006-06-15 | Oskar Kalb | Pharmaceutical compositions comprising fluvastatin |
| SE0102888D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| SE0102887D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| SE0102886D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| TWI338583B (en) | 2004-05-20 | 2011-03-11 | Otsuka Pharma Co Ltd | Solid pharmaceutical formulation |
| EP1803447B1 (en) * | 2004-09-09 | 2009-07-22 | Psicofarma, S.A. De C.V. | Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE795766A (fr) * | 1972-02-22 | 1973-08-22 | Lilly Co Eli | Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules |
| US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4520009A (en) * | 1983-11-28 | 1985-05-28 | Verex Laboratories, Inc. | Sustained released aspirin formulation |
| DE3346571A1 (de) * | 1983-12-23 | 1985-07-04 | Bayer Ag, 5090 Leverkusen | Oral retardierte acetylsalicylsaeureformulierungen |
| KR850700212A (ko) * | 1984-03-21 | 1985-12-26 | 죠지 드모트 | 서방성 약제학적 캼셀제 |
-
1986
- 1986-10-09 GB GB868624213A patent/GB8624213D0/en active Pending
-
1987
- 1987-09-25 NL NL8702294A patent/NL8702294A/nl not_active Application Discontinuation
- 1987-09-25 HU HU874311A patent/HU201875B/hu not_active IP Right Cessation
- 1987-10-02 BE BE8701131A patent/BE1000732A5/fr not_active IP Right Cessation
- 1987-10-02 FR FR878713759A patent/FR2604902B1/fr not_active Expired - Lifetime
- 1987-10-02 CH CH3838/87A patent/CH675831A5/de not_active IP Right Cessation
- 1987-10-03 DE DE19873733540 patent/DE3733540A1/de not_active Withdrawn
- 1987-10-06 IL IL84104A patent/IL84104A0/xx unknown
- 1987-10-06 LU LU87009A patent/LU87009A1/fr unknown
- 1987-10-06 KR KR870011168A patent/KR880004801A/ko not_active Application Discontinuation
- 1987-10-07 FI FI874414A patent/FI874414A/fi not_active IP Right Cessation
- 1987-10-07 AU AU79420/87A patent/AU7942087A/en not_active Abandoned
- 1987-10-07 GB GB8723515A patent/GB2195893B/en not_active Expired - Lifetime
- 1987-10-07 GR GR871550A patent/GR871550B/el unknown
- 1987-10-07 NZ NZ222083A patent/NZ222083A/en unknown
- 1987-10-07 PT PT85880A patent/PT85880B/pt not_active IP Right Cessation
- 1987-10-07 NO NO874200A patent/NO874200L/no unknown
- 1987-10-08 DK DK527487A patent/DK527487A/da not_active Application Discontinuation
- 1987-10-08 ES ES8702873A patent/ES2014518A6/es not_active Expired - Lifetime
- 1987-10-08 CA CA000548872A patent/CA1332809C/en not_active Expired - Lifetime
- 1987-10-08 IT IT48469/87A patent/IT1221493B/it active
- 1987-10-08 JP JP62256149A patent/JPS63101334A/ja active Pending
- 1987-10-08 SE SE8703889A patent/SE8703889L/ not_active Application Discontinuation
- 1987-10-08 PH PH35906A patent/PH24227A/en unknown
- 1987-10-09 ZA ZA877617A patent/ZA877617B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT52958A (en) | 1990-09-28 |
| PT85880B (pt) | 1990-07-31 |
| FR2604902B1 (fr) | 1991-04-26 |
| FI874414A0 (fi) | 1987-10-07 |
| CA1332809C (en) | 1994-11-01 |
| PT85880A (en) | 1987-11-01 |
| SE8703889L (sv) | 1988-04-10 |
| ZA877617B (en) | 1989-05-30 |
| HU201875B (en) | 1991-01-28 |
| GB2195893B (en) | 1991-05-08 |
| ES2014518A6 (es) | 1990-07-16 |
| DK527487D0 (da) | 1987-10-08 |
| PH24227A (en) | 1990-05-04 |
| FI874414A (fi) | 1988-04-10 |
| GB8723515D0 (en) | 1987-11-11 |
| DK527487A (da) | 1988-04-10 |
| KR880004801A (ko) | 1988-06-27 |
| NL8702294A (nl) | 1988-05-02 |
| AU7942087A (en) | 1988-04-14 |
| FR2604902A1 (fr) | 1988-04-15 |
| GB8624213D0 (en) | 1986-11-12 |
| GB2195893A (en) | 1988-04-20 |
| NZ222083A (en) | 1991-05-28 |
| CH675831A5 (da) | 1990-11-15 |
| IT8748469A0 (it) | 1987-10-08 |
| IL84104A0 (en) | 1988-03-31 |
| NO874200D0 (no) | 1987-10-07 |
| SE8703889D0 (sv) | 1987-10-08 |
| DE3733540A1 (de) | 1988-04-14 |
| GR871550B (en) | 1988-02-15 |
| JPS63101334A (ja) | 1988-05-06 |
| BE1000732A5 (fr) | 1989-03-21 |
| IT1221493B (it) | 1990-07-06 |
| NO874200L (no) | 1988-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5658172B2 (ja) | アムロジピン及びロサルタンを含む固形薬剤学的組成物及びその製造方法 | |
| CA2629670C (fr) | Forme galenique secable permettant une liberation modifiee du principe actif | |
| EP2605757B1 (fr) | Formulations a base de nalbuphine et leurs utilisations | |
| AU2014354475B2 (en) | Pharmaceutical combination formulation comprising amlodipine, losartan and rosuvastatin | |
| NO333936B1 (no) | Oralt farmasøytisk preparat som inneholder minst to separate formuleringer | |
| EA019614B1 (ru) | Усовершенствованная фармацевтическая композиция, содержащая антагонист дигидропиридинкальциевого канала, и способ ее получения | |
| TW201111368A (en) | Solid pharmaceutical fixed dose compositions comprising irbesartan, and amlodipine, their preparation and their therapeutic application | |
| CA2287800C (fr) | Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellulose a titre d'agents desintegrants, et procede d'obtention | |
| BE1000661A4 (fr) | Nouvelles compositions pharmaceutiques a base de ketotifene. | |
| LU87009A1 (fr) | Compositions pharmaceutiques a liberation prolongee | |
| TWI714560B (zh) | 包含安洛待平（ａｍｌｏｄｉｐｉｎｅ）、洛沙坦（ｌｏｓａｒｔａｎ）及氯薩利酮（ｃｈｌｏｒｔｈａｌｉｄｏｎｅ）的醫藥複合調配物 | |
| EP1781295A1 (fr) | Composition pharmaceutique sous forme de comprime a residence gastrique contenant un principe actif | |
| EP0983065A1 (fr) | Composition pharmaceutique a residence gastrique | |
| RU2698703C2 (ru) | Твердая фармацевтическая композиция, содержащая амлодипин и лозартан | |
| CA2853117C (en) | Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof | |
| EP1465607B1 (fr) | Compositions pharmaceutiques a liberation modifiee | |
| JP4945043B2 (ja) | モルシドミンの放出時間延長を伴う経口投与用新規生薬製剤 | |
| CA2611125A1 (fr) | Formulation a liberation prolongee de principes actifs de medicaments | |
| TW201006826A (en) | Method of treatment using eprosartan | |
| FR2560047A1 (fr) | Compositions de bromocriptine | |
| CA2642414A1 (en) | Rapid release irbesartan-containing pharmaceutical composition | |
| LU86615A1 (fr) | Nouvelle formulation a liberation prolongee | |
| EP4045016A1 (fr) | Comprimé à libération prolongée de la molsidomine | |
| Jagdale et al. | Superdisintegrant selection for tramadol dispersible tablets | |
| Uslu | Formulation development and characterization of liquisolid tablets containing clozapine |